Superinvestor Tracker
← All Investors

ASCENDIS PHARMA A/S

ASND 2.25 04-01-28

Holders

1

Combined Value

$70M

Combined Shares

47,794,000

Investor Activity

$0.90$1.19$1.47$1.75Q2'24Q3'24Q4'24Q1'25Q2'25Q3'25Q4'25Q1'26▲4▲3 ▼1▲2▲1 ▼3▼3▼1▼2▲1 ▼1
BUYSELLImplied priceClick a quarter to see who traded

Held By

InvestorValue% of PortfolioAvg Buy PriceGainLast ActivityAs of
Steve Cohen - Point72$70M0.09%~$1.32—Bought Q1 2026Q1 2026

Recent Activity

QuarterInvestorActionEst. ValueEst. Price
Q1 2026Steve Cohen - Point72BUY+$40M~$1.47
Q1 2026Howard Marks - Oaktree CapitalSOLD OUT−$994K~$1.42
Q4 2025Israel Englander - Millennium ManagementSOLD OUT−$2M~$1.37
Q4 2025Howard Marks - Oaktree CapitalSELL−$426K~$1.42
Q3 2025Howard Marks - Oaktree CapitalSELL−$414K~$1.36
Q2 2025Howard Marks - Oaktree CapitalSELL−$11M~$1.25
Q2 2025Steve Cohen - Point72SELL−$5M~$1.25
Q2 2025Ken Griffin - Citadel AdvisorsSOLD OUT−$393K~$1.19
Q1 2025Israel Englander - Millennium ManagementSELL−$10M~$1.19
Q1 2025Steve Cohen - Point72SELL−$8M~$1.19
Q1 2025Howard Marks - Oaktree CapitalSELL−$5M~$1.19
Q1 2025Ken Griffin - Citadel AdvisorsNEW BUY+$393K~$1.19
Q4 2024Steve Cohen - Point72BUY+$15M~$1.10
Q4 2024Howard Marks - Oaktree CapitalBUY+$2M~$1.10
Q3 2024Howard Marks - Oaktree CapitalBUY+$4M~$1.17
Q3 2024Israel Englander - Millennium ManagementBUY+$4M~$1.17
Q3 2024Steve Cohen - Point72BUY+$2M~$1.17
Q3 2024Ken Griffin - Citadel AdvisorsSOLD OUT−$1M~$1.12
Q2 2024Steve Cohen - Point72NEW BUY+$16M~$1.12
Q2 2024Howard Marks - Oaktree CapitalNEW BUY+$9M~$1.12
Q2 2024Israel Englander - Millennium ManagementNEW BUY+$7M~$1.12
Q2 2024Ken Griffin - Citadel AdvisorsNEW BUY+$1M~$1.12

Ownership History

PeriodHoldersTotal SharesΔ SharesTotal ValueImplied Price
Q1 2026147,794,000+130.9%$70M$1.47
Q4 2025220,700,000−8.0%$29M$1.42
Q3 2025322,500,000−1.3%$30M$1.37
Q2 2025322,804,000−36.8%$28M$1.25
Q1 2025436,098,000−35.5%$42M$1.19
Q4 2024356,002,000+42.2%$61M$1.10
Q3 2024339,369,000+29.2%$45M$1.17
Q2 2024430,476,000—$34M$1.12